Revvity (RVTY) Nyanmɛn Kpɛn
AI bɛ́nɛ́nɛ́: RVTY
AI bɛ sɔhɛn sɛn na ɛbɛ yɛ a ɛwɔ nna a ɛdi akyi, nnwɔtwe no awieeɛ ne bosome no awieeɛ. Nsakraeɛ no yɛ nea wɔhwɛ firi sika a ɛwɔ hɔ seesei. Eyinom yɛ nkyɛmu nhyehyɛeɛ, ɛnyɛ nkyɛmu a wɔde bɛyɛ adwuma.
Prix su les 6 mois derniers
Premium ɛn nyɛ AI sika tɔnɔw 1 da, 1 kɛsɛli kɛn 1 bɛn fɔlɔ ni sika tɔnɔw a ni ahunye bɛɛ.
Yɛ́lɛ́ Premium🔒 Nzɛnkan nyinmɛn
Kpɛnɛn nyanmiɛn su lɛlɛ su — kpɛnɛn nyanmiɛn su lɛlɛ kun'n su, su'n su kpɛnɛn su lɛlɛ kun'n su — yɛ Premium su.
Yɛ́lɛ́ PremiumNyanmiɛn nɛnɛn
Revvity, Inc. develops multi-omics technologies. Multi-omics is a comprehensive analytical approach in biology and medicine that assesses the interplay of various variables, including genomic, metabolomic, and other indicators. This approach enhances the understanding of biological processes, identifies biomarkers, delineates disease subtypes, and determines effective treatment and prevention strategies. In addition, the company provides information technology solutions to pharmaceutical and biotechnology companies. Revvity serves its customers in the United States.
